Design and synthesis of potent nonpeptidic farnesyltransferase inhibitors based on a terphenyl scaffold

被引:38
|
作者
Ohkanda, J
Lockman, JW
Kothare, MA
Qian, YM
Blaskovich, MA
Sebti, SM
Hamilton, AD
机构
[1] Yale Univ, Dept Chem, New Haven, CT 06520 USA
[2] Univ S Florida, Drug Discovery Program, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA
[3] Univ S Florida, Dept Oncol & Biochem, Tampa, FL 33612 USA
[4] Univ S Florida, Dept Mol Biol, Tampa, FL 33612 USA
关键词
D O I
10.1021/jm0103099
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
By modification of key carboxylate, hydrophobic, and zinc-binding groups projected from a sterically restricted terphenyl scaffold, a series of simple and nonpeptide mimetics of the Cys-Val-Ile-Met tetrapeptide substrate of protein farnesyltransferase (FTase) have been designed and synthesized. A crystal structure of 4-nitro-2-phenyl-3'-methoxycarbonylbiphenyl shows that the triphenyl fragment provides a large hydrophobic surface that potentially mimics the hydrophobic side chains of the three terminal residues in the tetrapeptide. 2-Phenyl-3-(N-(1-(4-eyanobenzyl)-1H-imidazol-5-yl)methyl)amino-3'carboxylbiphenyl, in which the free thiol group was replaced with a 1-(4-cyanobenzyl)imidazole group, shows submicromolar inhibition activity against FTase in vitro and inhibits H-Ras processing in whole cells.
引用
收藏
页码:177 / 188
页数:12
相关论文
共 50 条
  • [1] Design and synthesis of arylsulfonylthiosemicarbazides as potent, nonpeptidic cyclophillin inhibitors
    Wu, YQ
    Wilkinson, DE
    Hamilton, GS
    Steiner, J
    Hamilton, S
    Thomas, BE
    Massuda, E
    Fuller, M
    Stathis, M
    Belyakov, SA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2573 - U2574
  • [2] Design and synthesis of potent and selective aldose reductase inhibitors based on pyridylthiadiazine scaffold
    Chen, Xin
    Yang, Yanchun
    Ma, Bing
    Zhang, Shuzhen
    He, Minlan
    Gui, Dequan
    Hussain, Saghir
    Jing, Chaojun
    Zhu, Changjin
    Yu, Qun
    Liu, Yan
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2011, 46 (05) : 1536 - 1544
  • [3] Design and Preparation of Potent, Nonpeptidic, Bioavailable Renin Inhibitors
    Bezencon, Olivier
    Bur, Daniel
    Weller, Thomas
    Richard-Bildstein, Sylvia
    Remen, Lubos
    Sifferlen, Thierry
    Corminboeuf, Olivier
    Grisostomi, Corinna
    Boss, Christoph
    Prade, Lars
    Delahaye, Stephane
    Treiber, Alexander
    Strickner, Panja
    Binkert, Christoph
    Hess, Patrick
    Steiner, Beat
    Fischli, Walter
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (12) : 3689 - 3702
  • [4] Structure-Based Design and Synthesis of Potent, Ethylenediamine-Based, Mammalian Farnesyltransferase Inhibitors as Anticancer Agents
    Fletcher, Steven
    Keaney, Erin Pusateri
    Cummings, Christopher G.
    Blaskovich, Michelle A.
    Hast, Michael A.
    Glenn, Matthew P.
    Chang, Sung-Youn
    Bucher, Cynthia J.
    Floyd, Ryan J.
    Katt, William P.
    Gelb, Michael H.
    Van Voorhis, Wesley C.
    Beese, Lorena S.
    Sebti, Said M.
    Hamilton, Andrew D.
    JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (19) : 6867 - 6888
  • [5] Design and synthesis of non-peptide Ras CAAX mimetics as potent farnesyltransferase inhibitors
    Qian, YM
    Vogt, A
    Sebti, SM
    Hamilton, AD
    JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (01) : 217 - 223
  • [6] Design and Synthesis of Natural Product-Like Terphenyl as Potent Topoisomerase IIα Inhibitors
    Guan, Mengjia
    Qiu, Jin
    Lu, Chunhua
    Zhao, Baobing
    Shen, Yuemao
    CHINESE JOURNAL OF ORGANIC CHEMISTRY, 2018, 38 (11) : 3039 - 3047
  • [7] New indolizine-chalcones as potent inhibitors of human farnesyltransferase: Design, synthesis and biological evaluation
    Moise, Iuliana-Monica
    Ghinet, Alina
    Belei, Dalila
    Dubois, Joelle
    Farce, Amaury
    Bicu, Elena
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (15) : 3730 - 3734
  • [8] Models of ternary complexes for nonpeptidic farnesyltransferase inhibitors: Insights into structure-based screen and design of potential anticancer therapeutics
    Xu, K
    Perola, E
    Prendergast, FG
    Pang, YP
    JOURNAL OF MOLECULAR MODELING, 1999, 5 (10) : 203 - 217
  • [9] β-substituted cyclohexanecarboxamide:: A nonpeptidic framework for the design of potent inhibitors of cathepsin K
    Crane, SN
    Black, WC
    Palmer, JT
    Davis, DE
    Setti, E
    Robichaud, J
    Paquet, J
    Oballa, RM
    Bayly, CI
    McKay, DJ
    Somoza, JR
    Chauret, N
    Seto, C
    Scheigetz, J
    Wesolowski, G
    Massé, F
    Desmarais, S
    Ouellet, M
    JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (03) : 1066 - 1079
  • [10] Models of Ternary Complexes for Nonpeptidic Farnesyltransferase Inhibitors: Insights into Structure-Based Screen and Design of Potential Anticancer Therapeutics
    Kun Xu
    Emanuele Perola
    Franklyn G. Prendergast
    Yuan-Ping Pang
    Molecular modeling annual, 1999, 5 : 203 - 217